Latest price-to-book ratio
Relmada Therapeutics Price-to-book ratio
Direct answer
Relmada Therapeutics's price-to-book ratio is 1.69x.
The verified market snapshot reports 1.69x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 1.69x
Explore related company data
View Relmada Therapeutics's market capitalizationView Relmada Therapeutics's return on equityView Relmada Therapeutics's dividend yieldView Relmada Therapeutics's 52-week price rangeView Relmada Therapeutics's profit marginView all Relmada Therapeutics key metricsReturn to Relmada Therapeutics profile